Citadel Advisors »

Evogene shares owned by Citadel Advisors

Quarter-by-quarter ownership of Evogene (EVGN) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Evogene

Tip: Access up to 7 years of quarterly data

All positions including Evogene held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evogene by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $49k 59k 0.84
2023-09-30 $18k 30k 0.59
2023-06-30 $20k 18k 1.07
2023-03-31 $52k 83k 0.63
2022-12-31 $79k 113k 0.70
2022-06-30 $40k 54k 0.74
2022-03-31 $107k 82k 1.30
2021-12-31 $326k 202k 1.61
2021-09-30 $0 170k 0.00
2021-06-30 $1.3M 386k 3.42
2021-03-31 $2.1M 424k 5.04
2019-09-30 $31k 19k 1.60
2018-12-31 $28k 14k 2.02